Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Graham

Showing results (461-470 of 481) with videos related to

Pageof 49
Sort By:
Scandinavian Journal of Gastroenterology|November 7, 2009
Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesionsJin Seok Jang, Seok Reyol Choi, David Y Graham, et al.
Gastroenterology|May 1, 2017
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-AnalysisJames K Y Hooi, Wan Ying Lai, Wee Khoon Ng, et al.
Microbial Ecology|July 5, 2021
Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in HumansLi Jiao, Themistoklis Kourkoumpetis, Diane Hutchinson, et al.
European Heart Journal|October 12, 2017
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) TrialFrank Ruschitzka, Jeffrey S Borer, Henry Krum, et al.
The New England Journal of Medicine|December 14, 2016
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for ArthritisSteven E Nissen, Neville D Yeomans, Daniel H Solomon, et al.
The American Journal of Gastroenterology|June 25, 2025
Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized TrialPing-I Hsu, Chien-Lin Chen, Chih-An Shih, et al.
Journal of Virology|October 9, 2015
Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and PathophysiologyKapil Saxena, Sarah E Blutt, Khalil Ettayebi, et al.
The Journal of Infectious Diseases|September 12, 2014
Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adultsDavid I Bernstein, Robert L Atmar, G Marshall Lyon, et al.
Viruses|July 25, 2019
Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and ChallengesMary K Estes, Khalil Ettayebi, Victoria R Tenge, et al.
The Lancet. Microbe|December 21, 2024
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trialYi Hu, Zhen-Yu Zhang, Fen Wang, et al.
Pageof 49

Showing results (461-470 of 481) with videos related to

Sort By:
Pageof 49
Scandinavian Journal of Gastroenterology|November 7, 2009
Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesionsJin Seok Jang, Seok Reyol Choi, David Y Graham, et al.
Gastroenterology|May 1, 2017
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-AnalysisJames K Y Hooi, Wan Ying Lai, Wee Khoon Ng, et al.
Microbial Ecology|July 5, 2021
Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in HumansLi Jiao, Themistoklis Kourkoumpetis, Diane Hutchinson, et al.
European Heart Journal|October 12, 2017
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) TrialFrank Ruschitzka, Jeffrey S Borer, Henry Krum, et al.
The New England Journal of Medicine|December 14, 2016
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for ArthritisSteven E Nissen, Neville D Yeomans, Daniel H Solomon, et al.
The American Journal of Gastroenterology|June 25, 2025
Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized TrialPing-I Hsu, Chien-Lin Chen, Chih-An Shih, et al.
Journal of Virology|October 9, 2015
Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and PathophysiologyKapil Saxena, Sarah E Blutt, Khalil Ettayebi, et al.
The Journal of Infectious Diseases|September 12, 2014
Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adultsDavid I Bernstein, Robert L Atmar, G Marshall Lyon, et al.
Viruses|July 25, 2019
Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and ChallengesMary K Estes, Khalil Ettayebi, Victoria R Tenge, et al.
The Lancet. Microbe|December 21, 2024
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trialYi Hu, Zhen-Yu Zhang, Fen Wang, et al.
Pageof 49